METHOD OF ESTIMATION OF ANTIBACTERIAL THERAPY ADEQUACY FOR COMMUNITY-ACQUIRED PNEUMONIA Russian patent published in 2009 - IPC A61B5/00 

FIELD: medicine; pulmonology.

SUBSTANCE: invention can be used for determination of uniform quantitative indicator reflecting adequacy degree of antibacterial therapy considering various (quantitative, qualitative and time) parameters characterising their application for community-acquired pneumonia. Estimation of antibacterial therapy adequacy for community-acquired pneumonias consists in estimation of its elements with deriving uniform index, allowing for conclusion referring to ideal version of antibiotics therapy, a version of adequate therapy, inadequate therapy version, imitation version or absence of therapy. Thus estimated elements are as follows: number of points reflecting timeliness of antibiotics therapy from the moment pneumonia started, number of points reflecting timeliness of antibiotics therapy from the moment pneumonia diagnosed; number of points (or total for combined therapy), reflecting antibiotics dose size relative to maximally allowed; number of points (or total for combined therapy), reflecting methods of antibiotics introduction from the moment therapy started; number of points (or total for combined therapy), reflecting spectrum of antibiotics action from the moment therapy started; number of points (or total for combined therapy), reflecting multiplication factor of antibiotics introduction; number of points reflecting degree of combined antibiotics therapy; number of points reflecting antibiotic change flexibility.

EFFECT: reliable estimate of adequacy degree of antibacterial therapy for community-acquired pneumonia treatment.

2 ex